Marsh McLennan (MRSH) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Dec, 2025Executive summary
Revenue for Q1 2025 grew 9% to $7.1 billion, with 4% underlying growth and strong contributions from acquisitions, despite a 2% currency headwind.
Adjusted operating income increased 8% to $2.2 billion; adjusted EPS rose 5% to $3.06, while GAAP EPS decreased 1% to $2.79 due to higher interest expense.
Net income attributable to the company was $1.4 billion.
All business segments posted growth; integration of McGriff is on track and contributing.
Macroeconomic and geopolitical risks, including global trade negotiations and inflation, are impacting business confidence and market volatility.
Financial highlights
Q1 2025 consolidated revenue: $7.1B (up 9%); operating income: $2.0B (up 4%); adjusted operating income: $2.2B (up 8%).
Adjusted operating margin: 31.8%; GAAP EPS: $2.79; adjusted EPS: $3.06 (up 5%).
Net income: $1.4B; net income margin: ~19.7%.
$300M in share repurchases and $405M in dividends paid in Q1.
Cash and cash equivalents at quarter-end: $1.6B; total assets: $57.0B.
Outlook and guidance
Expect mid-single digit underlying revenue growth, margin expansion, and solid adjusted EPS growth for 2025, supported by operating efficiencies and investments.
Guidance is based on current conditions; ongoing trade and macroeconomic uncertainty could materially impact results.
Management highlights resilience and continued demand for advisory services amid uncertain market conditions.
Anticipate $4.5B capital deployment in 2025 across dividends, acquisitions, and share repurchases.
Adjusted effective tax rate expected between 25%-26% for 2025.
Latest events from Marsh McLennan
- 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and incentive plan, all board-backed.MRSH
Proxy Filing1 Dec 2025 - Q2 2025 delivered 12% revenue growth, 11% EPS gain, and a 10% dividend increase.MRSH
Q2 20255 Nov 2025 - Q3 revenue up 11%, adjusted EPS up 11%, Thrive targets $400M savings, rebranding to Marsh.MRSH
Q3 202520 Oct 2025